Trials / Completed
CompletedNCT02856282
Drug Utilization Study for Pirinase Hayfever Relief
Drug Utilization Study for Pirinase Hayfever Relief for Adults 0.05% Nasal Spray
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 46 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 4 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose is to obtain real-world information on how consumers are complying with the product labelling This study will coincide with the launch of Pirinase Hayfever Relief for Adults 0.05% Nasal Spray in the United Kingdom (UK).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pirinase Hayfever Relief for Adults 0.05% Nasal Spray | Aqueous suspension of 0.05% micronised fluticasone propionate.Each actuation contains 50 micrograms of fluticasone propionate |
Timeline
- Start date
- 2016-02-15
- Primary completion
- 2018-03-31
- Completion
- 2018-03-31
- First posted
- 2016-08-04
- Last updated
- 2019-06-24
- Results posted
- 2019-06-24
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02856282. Inclusion in this directory is not an endorsement.